Stay updated on AZD5305+New Hormonal Agents in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the AZD5305+New Hormonal Agents in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the AZD5305+New Hormonal Agents in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov record for the Stempeucel study in patients with critical limb ischemia due to Buerger’s disease is displayed, including its study details, participation criteria, locations, and outcome measures.SummaryDifference56%

- Check13 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2. The study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check20 days agoChange DetectedA site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content. It appears above the ClinicalTrials.gov 403 error page.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on an otherwise unchanged 403 Forbidden page.SummaryDifference0.2%

- Check34 days agoChange DetectedThe error page’s footer revision identifier changes from v3.7.0 to v3.7.1; the study record remains unavailable behind a 403 Forbidden screen.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error and navigation header, replacing the previous study record content and effectively removing visible study details such as conditions, locations, and investigators.SummaryDifference19%

Stay in the know with updates to AZD5305+New Hormonal Agents in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD5305+New Hormonal Agents in Metastatic Prostate Cancer Clinical Trial page.